Protocol to isolate, expand, and activate human type 2 innate lymphoid cells to study immune checkpoint function

Read full text Summarise with VIRAT
Authors: Cecilia Ciancaglini, Silvia Santopolo, Paola Vacca, Lorenzo Moretta, Linda Quatrini
Cited by: 0
References: 1

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Type 2 innate lymphoid cells (ILC2s) are a subset of innate lymphoid cells involved in allergic diseases, tissue repair, and tumor immunity. Here, we present a protocol to study the function of immune checkpoint receptors on ILC2s in vitro using plate-bound recombinant ligands. We describe steps for the enrichment, expansion, and purification of human ILC2s from healthy donors’ peripheral blood. For complete details on the use and execution of this protocol, please refer to Ciancaglini et al. 1 1. Ciancaglini, C. ∙ Santopolo, S. ∙ Martini, S. ... Macrophages regulate PD-1 and CTLA-4 expression on ILC2s and their responsiveness in the tumor microenvironment Cell. Mol. Immunol. 2025; 22 :1491-1505 Crossref Scopus (5) PubMed Google Scholar

Fields of Study & Subjects

IL-33 ST2 and ILC Pathways Cancer Immunotherapy and Biomarkers T-cell and B-cell Immunology

Publication details

Journal / source
STAR Protocols
Volume
7
Issue
2
Pages
104461–104461
Publication date
25 March 2026
Language
EN